Published in

Elsevier, EBioMedicine, (79), p. 104010, 2022

DOI: 10.1016/j.ebiom.2022.104010

Links

Tools

Export citation

Search in Google Scholar

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response

Journal article published in 2022 by Fabio Scirocchi ORCID, Simone Scagnoli ORCID, Andrea Botticelli ORCID, Alessandra Di Filippo ORCID, Chiara Napoletano, Ilaria Grazia Zizzari, Lidia Strigari, Silverio Tomao, Enrico Cortesi, Aurelia Rughetti, Paolo Marchetti, Marianna Nuti ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO